Related references
Note: Only part of the references are listed.How I treat acute myeloid leukemia in the era of new drugs
Courtney D. DiNardo et al.
BLOOD (2020)
Chemogenomics analysis of drug targets for the treatment of acute promyelocytic leukemia
Si Chen et al.
ANNALS OF HEMATOLOGY (2020)
Identification of a new cryptic PML-RARα fusion gene without t(15;17) and biallelic CEBPA mutation in a case of acute promyelocytic leukemia: a case detected only by RT-PCR but not cytogenetics and FISH
Zhanglin Zhang et al.
CANCER BIOLOGY & THERAPY (2020)
Advances in Pediatric Acute Promyelocytic Leukemia
Shannon E. Conneely et al.
CHILDREN-BASEL (2020)
Pathogenetic implication of fusion genes in acute promyelocytic leukemia and their diagnostic utility
S. M. Baba et al.
CLINICAL GENETICS (2019)
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2019)
FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias
Cecile Esnault et al.
BLOOD (2019)
STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype
G. Ciangola et al.
LEUKEMIA RESEARCH (2019)
An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3
Yang Cao et al.
ACTA HAEMATOLOGICA (2019)
Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse
Licia Iaccarino et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia
Antonio R. Lucena-Araujo et al.
BLOOD (2019)
Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1
Tomoo Osumi et al.
GENES CHROMOSOMES & CANCER (2019)
A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review
Yiping Liu et al.
ONCOTARGETS AND THERAPY (2019)
The Impact of Flt3 Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis
Gledson L. Picharski et al.
CANCERS (2019)
Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies
N. Noguera et al.
CANCERS (2019)
Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia
Licia Iaccarino et al.
GENES CHROMOSOMES & CANCER (2019)
PML/RARa blocks the differentiation and promotes the proliferation of acute promyelocytic leukemia through activating MYB expression by transcriptional and epigenetic regulation mechanisms
Genjie Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia
Jie Zhao et al.
LEUKEMIA (2019)
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy
Jorge Labrador et al.
LEUKEMIA & LYMPHOMA (2019)
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Gerrit J. Schuurhuis et al.
BLOOD (2018)
IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid
Samir Mazharuddin et al.
LEUKEMIA & LYMPHOMA (2018)
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
Jacqueline Lehmann-Che et al.
NATURE COMMUNICATIONS (2018)
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India
Nikhil Rabade et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2018)
Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia
Coline Gaillard et al.
BLOOD ADVANCES (2018)
Crosstalk between p53 modifiers at PML bodies
Sonja Matt et al.
MOLECULAR & CELLULAR ONCOLOGY (2018)
PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias
C. Ronchini et al.
LEUKEMIA (2017)
The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia
J. V. Jovanovic et al.
LEUKEMIA (2017)
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia
Claudia Brunetti et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Identification of a novel PML-RARG fusion in acute promyelocytic leukemia
J-S Ha et al.
LEUKEMIA (2017)
Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways
Li-Na Wang et al.
LEUKEMIA & LYMPHOMA (2017)
FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia
Chi Keung Cheng et al.
BLOOD (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia
Licia Iaccarino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion
Yoshimitsu Shimomura et al.
CANCER SCIENCE (2016)
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
V. Madan et al.
LEUKEMIA (2016)
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy
L. Cicconi et al.
LEUKEMIA (2016)
A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells
Andreas Reinisch et al.
NATURE MEDICINE (2016)
The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations
Mariam Ibanez et al.
PLOS ONE (2016)
Identification of a Novel Fusion Gene, IRF2BP2-RARA, in Acute Promyelocytic Leukemia
C. Cameron Yin et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
Alan K. Burnett et al.
LANCET ONCOLOGY (2015)
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet
E. Lengfelder et al.
LEUKEMIA (2015)
PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence
Lisa Ivanschitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Successful treatment of acute promyelocytic leukemia with a t(X;17)(p11.4;q21) and BCOR-RARA fusion gene
Satoshi Ichikawa et al.
CANCER GENETICS (2015)
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
Harry J. Iland et al.
LANCET HAEMATOLOGY (2015)
Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide
Yang Shen et al.
EBIOMEDICINE (2015)
GTF2I-RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid
Ji Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene
Esperanza Such et al.
ANNALS OF HEMATOLOGY (2014)
Understanding the molecular pathogenesis of acute promyelocytic leukemia
Francesco Lo-Coco et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2014)
Can we say farewell to monitoring minimal residual disease in acute promyelocytic leukaemia?
David Grimwade et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2014)
Autologous Is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission
Jennifer L. Holter Chakrabarty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia
Yirui Chen et al.
BLOOD (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Oral Arsenic and Retinoic Acid for Non-High-Risk Acute Promyelocytic Leukemia
Hong-Hu Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia
Hong-Hu Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Single-Nucleotide Polymorphism Array-Based Karyotyping of Acute Promyelocytic Leukemia
Ines Gomez-Segui et al.
PLOS ONE (2014)
Establishment of a Humanized APL Model via the Transplantation of PML-RARA-Transduced Human Common Myeloid Progenitors into Immunodeficient Mice
Hiromichi Matsushita et al.
PLOS ONE (2014)
PML nuclear bodies: Assembly and oxidative stress-sensitive sumoylation
Umut Sahin et al.
NUCLEUS (2014)
OBFC2A/RARA: a novel fusion gene in variant acute promyelocytic leukemia
Dahae Won et al.
BLOOD (2013)
MYC oncogene in myeloid neoplasias
M. Dolores Delgado et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial
Hong-Hu Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
NPMc + and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model
M. Mallardo et al.
LEUKEMIA (2013)
Acute promyelocytic leukemia with insertion of PML exon 7c: a novel variant transcript related to good prognosis that is not detected with real-time polymerase chain reaction
Yan Yi et al.
LEUKEMIA & LYMPHOMA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups
L. Riva et al.
BLOOD CANCER JOURNAL (2013)
Post-translational modifications of PML: consequences and implications
Xiwen Cheng et al.
FRONTIERS IN ONCOLOGY (2013)
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy
Ezhilarasi Chendamarai et al.
BLOOD (2012)
Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia
Sadia Saeed et al.
BLOOD (2012)
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3
Daniel Nowak et al.
GENES CHROMOSOMES & CANCER (2012)
Acute promyelocytic leukemia, arsenic, and PML bodies
Hugues de The et al.
JOURNAL OF CELL BIOLOGY (2012)
A PML-PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance
Keisuke Ito et al.
NATURE MEDICINE (2012)
A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia
Esperanza Such et al.
BLOOD (2011)
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy
Eva Barragan et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
FIP1L1/RARA with breakpoint at FIP1L1 intron 13: a variant translocation in acute promyelocytic leukemia
Juliane Menezes et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression
Lukas D. Wartman et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice
George S. Vassiliou et al.
NATURE GENETICS (2011)
Development of real-time quantitative polymerase chain reaction assays to tracks treatment response in retinoid resestant acute promyelocytic leukemia
Jelena V. Jovanovic et al.
FRONTIERS IN ONCOLOGY (2011)
BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
Yukiya Yamamoto et al.
BLOOD (2010)
PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
Joost H. A. Martens et al.
CANCER CELL (2010)
FISH-negative cryptic PML-RARA rearrangement detected by long-distance polymerase chain reaction and sequencing analyses: a case study and review of the literature
Min Jin Kim et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
Jose Cervera et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia
Letetia Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
A Case of a Novel PML/RARA Short Fusion Transcript with Truncated Transcription Variant 2 of the RARA Gene
Ivana Jeziskova et al.
MOLECULAR DIAGNOSIS & THERAPY (2010)
PML Nuclear Bodies
Valerie Lallemand-Breitenbach et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Acute promyelocytic leukemia with insertion of PML exon 7a and partial deletion of exon 3 of RARA: a novel variant transcript related to aggressive course and not detected with real-time polymerase chain reaction analysis
Tae Sung Park et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy
David Grimwade et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
Andrea Viale et al.
NATURE (2009)
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
Jiong Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
An acute promyelocytic leukaemia patient with a new atypical promyelocytic leukemia breakpoint
Natalia Cenfra et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia
Takeshi Kondo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
PML targeting eradicates quiescent leukaemia-initiating cells
Keisuke Ito et al.
NATURE (2008)
Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Valerie Lallemand-Breitenbach et al.
NATURE CELL BIOLOGY (2008)
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Rosa Bernardi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia
Alberto Catalano et al.
BLOOD (2007)
A large exon 6 break in V-form acute promyelocytic leukemia: relevance to clinical management
E. Bussaglia et al.
LEUKEMIA (2007)
PML-retinoic acid receptor α inhibits PML IV enhancement of PU.1-induced C/EBPFε expression in myeloid differentiation
Hitoshi Yoshida et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2007)
Using quantification of the PML-RAR alpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia
Carlos Santamaria et al.
HAEMATOLOGICA (2007)
Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia
Said Ismail et al.
ACTA HAEMATOLOGICA (2007)
Opinion -: How patients have benefited from mouse models of acute promyelocytic leukaemia
V Lallemand-Breitenbach et al.
NATURE REVIEWS CANCER (2005)
A role for PML3 in centrosome duplication and genome stability
ZX Xu et al.
MOLECULAR CELL (2005)
Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia
C Nicci et al.
LEUKEMIA (2005)
Physical and functional link of the leukemia-associated factors AML1 and PML
LA Nguyen et al.
BLOOD (2005)
PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation
D Kamashev et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
J Gabert et al.
LEUKEMIA (2003)
High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expression
P Westervelt et al.
BLOOD (2003)
Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia
MM Le Beau et al.
BLOOD (2003)
PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia
RA Padua et al.
NATURE MEDICINE (2003)
Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia
D Grimwade et al.
LEUKEMIA (2002)
The role of retinoids and retinoic acid receptors in normal hematopoiesis
SJ Collins
LEUKEMIA (2002)
Deconstructing PML-induced premature senescence
O Bischof et al.
EMBO JOURNAL (2002)
Identification of two atypical PML-RARα transcripts in two patients with acute promyelocytic leukemia
E Barragán et al.
LEUKEMIA RESEARCH (2002)
The role of PML in tumor suppression
P Salomoni et al.
CELL (2002)
Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type:: long-term follow-up in acute promyelocytic leukemia
JG Jurcic et al.
BLOOD (2001)
PML protein isoforms and the RBCC/TRIM motif
K Jensen et al.
ONCOGENE (2001)
Translocations of the RARα gene in acute promyelocytic leukemia
A Zelent et al.
ONCOGENE (2001)
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RARα isoforms:: a study of the PETHEMA group
M González et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Role of PML and PML-RARα in Mad-mediated transcriptional repression
MM Khan et al.
MOLECULAR CELL (2001)
In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice
H Kosugi et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia
PP Pandolfi
HUMAN MOLECULAR GENETICS (2001)
Positive and negative regulation of granulopoiesis by endogenous RARα
P Kastner et al.
BLOOD (2001)
Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARα and PLZF-RARα oncoproteins
EM Rego et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid:: effects in patients with newly diagnosed acute promyelocytic leukemia
E Lengfelder et al.
LEUKEMIA (2000)
Role of SUMO-1-modified PML in nuclear body formation
S Zhong et al.
BLOOD (2000)
Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation
S Minucci et al.
MOLECULAR CELL (2000)
Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers
RJ Lin et al.
MOLECULAR CELL (2000)
Share Paper
